Its announcement comes on the heels of an analogous licensing arrangement offered in February to Adastra Labs, which experienced until finally now centered on crafting cannabis extracts. Adastra's license also makes it possible for it to make and promote psilocybin and psilocin – hallucinogens much more commonly often called magic mushrooms that